Table 3.

Guidelines and recommendations for HPV vaccination.

Professional society, Country:	Solid organ transplant recipients (SOTR):	Healthy individuals:
SST, Denmark (32):	No recommendation.	Females from 12 to 18 years of age.
WHO (25):	All immunocompromised, including transplant recipients (regardless of whether they are receiving antiretroviral therapy).	Female from 9 to 14 years of age. If resources are available, the age range could be expanded up to 18 years and could also include males.
CDC, USA (20):	All immunocompromised both females and males, from 9 to 26 years of age.	Females from 9 to 26 years of age. Males from 9 – 21 years of age.
IDSA, USA (21, 33):	All SOTR from 11 to 26 years of age(21).	Females from 9 to 26 years of age(33).
PHAC, Canada (22, 34):	Before or after transplantation in females and males from 9 to 26 years of age(22).	Both females and males from 9 to 26 years of age(34).
AGDH, Australia (23, 35):	Before or after transplantation in both females and males from 9 years of age and above(23).	Both females and males from 9 to 18 years of age(35).
HSE, Ireland (24, 36):	Before or after transplantation in patients from 10 years of age and above(24).	Females and males may be given the vaccine from 9 to 26 years of age(36).

SST; Sundhedsstyrelsen (The Danish health authorities), WHO; World Health Organization, CDC; Center of disease control and prevention, IDSA; Infectious Diseases Society of America, PHAC; Public Health Agency of Canada, AGDH; Australian Government Department of Health, HSE; Health Service Executive.